PDLIM5, PDZ and LIM domain 5, 10611

N. diseases: 148; N. variants: 19
Disease: Hepatitis A ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019159
Disease: Hepatitis A
Hepatitis A 		0.050 Biomarker disease BEFREE Patients were classified into four categories: immune tolerant phase (IT, n = 36), immune clearance phase (IC, n = 81), low-replicative phase (LR, n = 31), and HBeAg-negative hepatitis phase (ENH, n = 36), based on clinical, biochemical, serological, HBV DNA level and histological data. 26427997 2016
CUI: C0019159
Disease: Hepatitis A
Hepatitis A 		0.050 GeneticVariation disease BEFREE They were classified into 4 phases: immune tolerance (IT) phase (n = 39), immune clearance (IC) phase (n = 48), low or no-replicative (LR) phase (n = 55), and HBeAg-negative hepatitis (ENH, n = 69). 25546679 2014
CUI: C0019159
Disease: Hepatitis A
Hepatitis A 		0.050 GeneticVariation disease BEFREE The patients were classified into 4 categories: immune tolerant phase (IT, n=9), immune clearance phase (IC, n=26), low-replicative phase (LR, n=131), and HBeAg-negative hepatitis (ENH, n=106). 22079974 2012
CUI: C0019159
Disease: Hepatitis A
Hepatitis A 		0.050 Biomarker disease BEFREE They were categorized into immune tolerance (IT, n=56), HBeAg-positive hepatitis (EPH, n=150), inactive carrier (IC, n=274) and HBeAg-negative hepatitis (ENH, n=165). 21645212 2011
CUI: C0019159
Disease: Hepatitis A
Hepatitis A 		0.050 GeneticVariation disease BEFREE Patients were categorized according to the phase of HBV-infection: HBeAg(+) immune tolerance phase (IT, n=30), immune clearance phase (IC, n=48), HBeAg(-) low-replicative phase (LR, n=68), HBeAg(-) hepatitis (ENH, n=68), and acute hepatitis B (n=12). 20207438 2010